Works matching Thalidomide

Results: 4338

Effects of Thalidomide and rhGM-CSF on Carbohydrate Metabolism in HL-60 Acute Promyelocytic Leukemia Cell Line.

Published in:

UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2011, v. 21, n. 3, p. 170, doi. 10.4999/uhod.11007

By:

BOYUNAGA, Hakan;
DIKMEN, Gunnur;
URAL, A. Ugur;
MELEKOGLU, Abdullah

Publication type:

Article

沙利度胺联合放疗对宫颈癌裸鼠移植瘤的 VEGF、bFGF、TNF-琢表达的影响.

Published in:

Progress in Modern Biomedicine, 2020, v. 20, n. 16, p. 3038, doi. 10.13241/j.cnki.pmb.2020.16.008

By:

邢天容;
吕敬媛;
朴英兰;
佟丽波;
张燕

Publication type:

Article

Behavioural, metabolic, and endothelial effects of the TNF-α suppressor thalidomide on rats subjected to chronic mild stress and fed an atherogenic diet.

Published in:

Canadian Journal of Physiology & Pharmacology, 2014, v. 92, n. 5, p. 375, doi. 10.1139/cjpp-2013-0446

By:

Ismail, Basma;
Aboul-Fotouh, Sawsan;
Mansour, Amal A.;
Shehata, Hanan H.;
Salman, Manal I.;
Ibrahim, Eman A.;
Hassan, Olfat A.;
Abdel-tawab, Ahmed M.

Publication type:

Article

Bortezomib with Thalidomide plus Dexamethasone Compared with Thalidomide plus Doxorubicin and Dexamethasone as Induction Therapy in Previously Untreated Multiple Myeloma Patients.

Published in:

Acta Haematologica, 2013, v. 129, n. 1, p. 35, doi. 10.1159/000339635

By:

Buda, Gabriele;
Orciuolo, Enrico;
Carulli, Giovanni;
Galimberti, Sara;
Ghio, Francesco;
Cervetti, Giulia;
Pelosini, Matteo;
Petrini, Mario

Publication type:

Article

Thalidomide in consecutive multiple myeloma patients: single-center analysis on practical aspects, efficacy, side effects and prognostic factors with lower thalidomide doses.

Published in:

European Journal of Haematology, 2008, v. 80, n. 4, p. 303, doi. 10.1111/j.1600-0609.2007.01022.x

By:

Haas, P. S.;
Denz, U.;
Ihorst, G.;
Engelhardt, M.

Publication type:

Article

Thalidomide–dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide–dexamethasone: a case-matched study in advanced multiple myeloma.

Published in:

European Journal of Haematology, 2007, v. 78, n. 4, p. 297, doi. 10.1111/j.1600-0609.2007.00823.x

By:

Offidani, Massimo;
Bringhen, Sara;
Corvatta, Laura;
Falco, Patrizia;
Marconi, Monica;
Avonto, Ilaria;
Piersantelli, Maria-Novella;
Polloni, Claudia;
Boccadoro, Mario;
Leoni, Pietro;
Palumbo, Antonio

Publication type:

Article

Myocardial infarction, symptomatic third degree atrioventricular block and pulmonary embolism caused by thalidomide: a case report.

Published in:

2015

By:

Shengyu Zhang;
Jing Yang;
Xiaofeng Jin;
Shuyang Zhang;
Zhang, Shengyu;
Yang, Jing;
Jin, Xiaofeng;
Zhang, Shuyang

Publication type:

journal article

One-year prospective nerve conduction study of thalidomide neuropathy in lupus erythematosus: Incidence, coasting effect and drug plasma levels.

Published in:

Lupus, 2021, v. 30, n. 6, p. 956, doi. 10.1177/0961203321998433

By:

Yuki, Emily Figueiredo Neves;
Soares, Renata;
Kupa, Léonard de Vinci Kanda;
Heise, Carlos Otto;
Aikawa, Nadia Emi;
Arnone, Marcelo;
Romiti, Ricardo;
Pedrosa, Tatiana do Nascimento;
Silva, Clovis Artur Almeida da;
Bonfa, Eloisa;
Pasoto, Sandra Gofinet

Publication type:

Article

Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.

Published in:

Leukemia & Lymphoma, 2010, v. 51, n. 8, p. 1444, doi. 10.3109/10428194.2010.486878

By:

Offidani, Massimo;
Leoni, Pietro;
Bringhen, Sara;
Corvatta, Laura;
Larocca, Alessandra;
Gentili, Silvia;
Oliva, Stefania;
Polloni, Claudia;
Galieni, Piero;
Catarini, Massimo;
Alesiani, Francesco;
Mele, Anna;
Brunori, Marino;
Blasi, Nicola;
Ferranti, Mario;
Visani, Giuseppe;
Boccadoro, Mario;
Palumbo, Antonio

Publication type:

Article

Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study.

Published in:

2017

By:

Leng, Yun;
Hou, Jian;
Jin, Jie;
Zhang, Mei;
Ke, Xiaoyan;
Jiang, Bin;
Pan, Ling;
Yang, Linhua;
Zhou, Fang;
Wang, Jianmin;
Wang, Zhao;
Liu, Li;
Li, Wei;
Shen, Zhixiang;
Qiu, Lugui;
Chang, Naibai;
Li, Jianyong;
Liu, Jing;
Pang, Hongyan;
Meng, Haitao

Publication type:

journal article

Thalidomide and Thalidomide Transformed by pH-Dependent Hydrolysis or by Liver Enzyme Treatment Does Not Impede the Proliferation of Endothelial Cells.

Published in:

Immunopharmacology & Immunotoxicology, 2008, v. 30, n. 2, p. 307, doi. 10.1080/08923970801925406

By:

Shannon, E.J.;
Sandoval, F.G.

Publication type:

Article

Thalidomide treatment for hypertrophic cutaneous lupus erythematosus.

Published in:

Journal of Dermatological Treatment, 2004, v. 15, n. 6, p. 365, doi. 10.1080/09546630410018094

By:

Gambini, D.;
Carrera, C.;
Passoni, E.;
Muratori, S.;
Berti, E.;
Caputo, R.

Publication type:

Article

Ultra low dose thalidomide in elderly patients with myeloma.

Published in:

2008

By:

Bowcock, Stella J.;
Minchom, Anna;
Yates, Lucy R.;
Ryali, Madan M.

Publication type:

Letter

Long term thalidomide therapy's efficacy and safety in transfusion dependent beta thalassemia major patients: a systematic review.

Published in:

Khyber Medical University Journal, 2024, v. 16, n. 3, p. 255

By:

Atta, Tahira;
Subhan, Zakia;
Nabi, Muhammad;
Nur-Ul-Ain;
Ali, Wajid

Publication type:

Article

Potential Novel Uses of Thalidomide: Focus on Palliative Care.

Published in:

Drugs, 2000, v. 60, n. 2, p. 273, doi. 10.2165/00003495-200060020-00003

By:

Peuckmann, V.;
Fisch, M.;
Bruera, E.

Publication type:

Article

Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia.

Published in:

British Journal of Haematology, 2001, v. 114, n. 1, p. 78, doi. 10.1046/j.1365-2141.2001.02918.x

By:

Barosi, Giovanni;
Grossi, Alberto;
Comotti, Benedetto;
Musto, Pellegrino;
Gamba, Gabriella;
Marchetti, Monia

Publication type:

Article

Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.

Published in:

2017

By:

García‐Sanz, Ramón;
Corchete, Luis Antonio;
Alcoceba, Miguel;
Chillon, María Carmen;
Jiménez, Cristina;
Prieto, Isabel;
García‐Álvarez, María;
Puig, Noemi;
Rapado, Immaculada;
Barrio, Santiago;
Oriol, Albert;
Blanchard, María Jesús;
Rubia, Javier;
Martínez, Rafael;
Lahuerta, Juan José;
González Díaz, Marcos;
Mateos, María Victoria;
San Miguel, Jesús Fernando;
Martínez‐López, Joaquín;
Sarasquete, María Eugenia

Publication type:

journal article

Randomized Phase II Trial of Thalidomide Alone versus Thalidomide Plus Interferon Alpha in Patients with Refractory Multiple Myeloma.

Published in:

Cancer Investigation, 2007, v. 25, n. 3, p. 140, doi. 10.1080/07357900701208808

By:

Chiou, Tzeon-Jye;
Wang, Teng-Hsu;
Chao, Tsu-Yi;
Lin, Sheng-Fung;
Tang, Jih-Luh;
Chen, Tsai-Yun;
Chang, Ming-Chih;
Hsueh, Erh-Jung;
Chen, Po-Min

Publication type:

Article

Thalidomide in the Management of Multiple Myeloma.

Published in:

Hematology, 2002, v. 7, n. 5, p. 291, doi. 10.1080/1024533021000037199

By:

Schey, S.A.

Publication type:

Article

Thalidomide : faites attention à la toxicité cardiaque !

Published in:

Journal de Pharmacie Clinique, 2019, v. 38, n. 3, p. 147, doi. 10.1684/jpc.2019.0415

By:

Driouach, Siham;
Mounir, Amina;
Elkhader, Salaheddine;
Hicham, Eddou;
Moudden, Mohamed Karim;
Mohamed, El Baaj;
Zinebi, Ali

Publication type:

Article

Utilisation des analogues de la thalidomide dans le traitement des hémopathies malignes.

Published in:

Hematologie, 2022, v. 28, n. 1, p. 55, doi. 10.1684/hma.2022.1718

By:

Willaume, Alexandre;
Renneville, Aline

Publication type:

Article

Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre.

Published in:

1998

By:

Fife, Kathryn;
Phillips, Robert H;
Howard, Mark R;
Bower, Mark;
Gracie, Fiona;
Fife, K;
Howard, M R;
Gracie, F;
Phillips, R H;
Bower, M

Publication type:

journal article

Age-related changes in patients with upper limb thalidomide embryopathy in the United Kingdom.

Published in:

Journal of Hand Surgery (17531934), 2023, v. 48, n. 8, p. 773, doi. 10.1177/17531934231164093

By:

Markiewicz, Magdalena;
Stirling, Paul;
Brennan, Susan;
Hooper, Geoffrey;
Lam, Wee

Publication type:

Article

Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats A. Bosco et al.: Effect of thalidomide and rosiglitazone on retinopathy.

Published in:

Diabetologia, 2003, v. 46, n. 12, p. 1669, doi. 10.1007/s00125-003-1234-1

By:

Bosco, A. A.;
Lerario, A. C.;
Santos, R. F.;
Wajchenberg, B. L.

Publication type:

Article

Evaluation of stability difference between asymmetric homochiral dimer in (S)-thalidomide crystal and symmetric heterochiral dimer in (RS)-thalidomide crystal.

Published in:

Phase Transitions, 2010, v. 83, n. 3, p. 223, doi. 10.1080/01411591003605986

By:

Suzuki, Toshiya;
Tanaka, Masahito;
Shiro, Motoo;
Shibata, Norio;
Osaka, Tetsuya;
Asahi, Toru

Publication type:

Article

Thalidomide for the treatment of angiodysplasia‐related recurrent gastrointestinal hemorrhage: Is low dose a safe and viable option?

Published in:

Clinical Case Reports, 2019, v. 7, n. 12, p. 2363, doi. 10.1002/ccr3.2501

By:

Patel, Harish;
Mehershahi, Shehriyar;
Shaikh, Danial Haris;
Makker, Jasbir;
Nayudu, Sureshkumar;
Remy, Prospere;
Chilimuri, Sridhar

Publication type:

Article

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1771, doi. 10.1038/leu.2009.98

By:

Giannopoulos, K.;
Dmoszynska, A.;
Kowal, M.;
Wąsik-Szczepanek, E.;
Bojarska-Junak, A.;
Rolinski, J.;
Döhner, H.;
Stilgenbauer, S.;
Bullinger, L.

Publication type:

Article

(Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.

Published in:

Annals of Hematology, 2012, v. 91, n. 11, p. 1779, doi. 10.1007/s00277-012-1520-4

By:

Wang, Anyou;
Duan, Qiaohong;
Liu, Xin;
Ding, Kaiyang;
Han, Yongsheng;
Zhu, Weibo;
Cai, Xiaoyan;
Wu, Jingsheng;
Sun, Zimin

Publication type:

Article

Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma.

Published in:

Annals of Hematology, 2010, v. 89, n. 8, p. 803, doi. 10.1007/s00277-010-0925-1

By:

Palumbo, A.;
Davies, F.;
Kropff, M.;
Bladé, J.;
Delforge, M.;
Costa, F. Leal Da;
Garcia Sanz, R.;
Schey, S.;
Facon, T.;
Morgan, G.;
Moreau, P.

Publication type:

Article

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

Published in:

Annals of Hematology, 2010, v. 89, n. 5, p. 489, doi. 10.1007/s00277-009-0871-y

By:

Hyeon-Seok Eom;
Yeo-Kyeoung Kim;
Joo-Seop Chung;
Kihyun Kim;
Hyo Jung Kim;
Ho Young Kim;
Jong-Youl Jin;
Young-Rok Do;
Suk-Joong Oh;
Cheolwon Suh;
Chu-Myong Seong;
Chul Soo Kim;
Dong Soon Lee;
Jae Hoon Lee

Publication type:

Article

A review of thalidomide and digestive system related diseases.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1543757

By:

Xi, Zhao;
Jie, Wang;
Long, Zou;
Shasha, Shi

Publication type:

Article

A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806).

Published in:

Journal of Neuro-Oncology, 2013, v. 111, n. 1, p. 33, doi. 10.1007/s11060-012-0987-0

By:

Alexander, Brian;
Wang, Meihua;
Yung, W.;
Fine, Howard;
Donahue, Bernadine;
Tremont, Ivo;
Richards, Ray;
Kerlin, Kevin;
Hartford, Alan;
Curran, Walter;
Mehta, Minesh

Publication type:

Article

A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas.

Published in:

Journal of Neuro-Oncology, 2012, v. 106, n. 3, p. 611, doi. 10.1007/s11060-011-0698-y

By:

Ruiz, Jimmy;
Case, Doug;
Enevold, Gina;
Rosdhal, Robin;
Tatter, Stephen;
Ellis, Thomas;
McQuellon, Richard;
McMullen, Kevin;
Stieber, Volker;
Shaw, Edward;
Lesser, Glenn

Publication type:

Article

A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study.

Published in:

Journal of Neuro-Oncology, 2010, v. 100, n. 2, p. 193, doi. 10.1007/s11060-010-0157-1

By:

Kim, Chae-Yong;
Kim, Seung-Ki;
Phi, Ji;
Lee, Min;
Kim, In;
Kim, Il;
Wang, Kyu-Chang;
Jung, Hye-Lim;
Lee, Mee;
Cho, Byung-Kyu

Publication type:

Article

Effectiveness of thalidomide for ankylosing spondylitis: a meta-analysis of randomized controlled trials in China.

Published in:

Clinical Rheumatology, 2022, v. 41, n. 10, p. 2929, doi. 10.1007/s10067-022-06220-0

By:

Wang, Dongsen;
Hu, Xuemei;
Yin, Xuan;
Cui, Chunying;
Yang, Xue;
Li, Yuqing;
Ding, Guoyong;
Wu, Qingjian

Publication type:

Article

Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis.

Published in:

Clinical Rheumatology, 2017, v. 36, n. 3, p. 725, doi. 10.1007/s10067-016-3511-7

By:

Raturi, Rita;
Patel, Avani;
Carter, John

Publication type:

Article

Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 6, p. 1521, doi. 10.1007/s10067-016-3256-3

By:

Wang, Dandan;
Chen, Haifeng;
Wang, Shiying;
Zou, Yaohong;
Li, Jing;
Pan, Jieping;
Wang, Xiangdang;
Ren, Tianli;
Zhang, Yu;
Chen, Zhiwei;
Feng, Xuebing;
Sun, Lingyun

Publication type:

Article

Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease.

Published in:

Clinical Rheumatology, 2008, v. 27, n. 3, p. 373, doi. 10.1007/s10067-007-0786-8

By:

Direskeneli, H.;
Ergun, T.;
Yavuz, S.;
Hamuryudan, V.;
Eksioglu-Demiralp, E.

Publication type:

Article

Do new therapeutic approaches (autotransplants, thalidomide, dexamethasone) improve the survival of patients with multiple myeloma followed in a rheumatology department?

Published in:

Clinical Rheumatology, 2006, v. 25, n. 2, p. 175, doi. 10.1007/s10067-005-1151-4

By:

El Mahou, S.;
Attal, M.;
Jamard, B.;
Constantin, A.;
Cantagrel, A.;
Mazières, B.;
Arnaud, C.;
Laroche, M.

Publication type:

Article

Thalidomide potentiates etoposide-induced apoptosis in murine neuroblastoma through suppression of NF-κB activation.

Published in:

2018

By:

Hiramatsu, Tomomasa;
Yoshizawa, Jyoji;
Miyaguni, Kazuaki;
Sugihara, Tetsuro;
Harada, Atsushi;
Kaji, Sayuri;
Uchida, Goki;
Kanamori, Daisuke;
Baba, Yuji;
Ashizuka, Shuichi;
Ohki, Takao

Publication type:

journal article

Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma.

Published in:

Oncology, 2012, v. 82, n. 1, p. 59, doi. 10.1159/000336126

By:

Shao, Yu-Yun;
Lin, Zhong-Zhe;
Hsu, Chiun;
Lee, Kuan-Der;
Hsiao, Chi-Huang;
Lu, Yen-Shen;
Huang, Chien-Chung;
Shen, Yin-Chun;
Hsu, Chih-Hung;
Cheng, Ann-Lii

Publication type:

Article

Efficacy and Tolerability of Low-Dose Thalidomide as First-Line Systemic Treatment of Patients with Advanced Hepatocellular Carcinoma.

Published in:

Oncology, 2007, v. 72, p. 67, doi. 10.1159/000111709

By:

Yau, Thomas;
Chan, Pierre;
Wong, Hilda;
Ng, Kelvin K.;
Siu-Ho Chok;
Tan-To Cheung;
Lam, Vincent;
Epstein, Richard J.;
Sheung-Tat Fan;
Poon, Ronnie T.P.

Publication type:

Article

Thalidomide-Induced Primary Amenorrhea in a Patient With HbE/Beta-Thalassemia.

Published in:

JCEM Case Reports, 2023, v. 1, n. 3, p. 1, doi. 10.1210/jcemcr/luad057

By:

Singha, Arijit;
Mukhopadhyay, Pradip;
Ghosh, Sujoy

Publication type:

Article

Molecular Encapsulation of Thalidomide with Sulfobutyl Ether-7 β-Cyclodextrin for Immediate Release Property: Enhanced In Vivo Antitumor and Antiangiogenesis Efficacy in Mice.

Published in:

Drug Development & Industrial Pharmacy, 2008, v. 34, n. 2, p. 149, doi. 10.1080/03639040701484486

By:

Kale, Rajendrakumar;
Tayade, Pralhad;
Saraf, Madhusudan;
Juvekar, Aarti

Publication type:

Article

The Role of Thalidomide and Its Analogs in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Systematic Review.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5404, doi. 10.3390/jcm13185404

By:

Ugur, Mehmet Can;
Baysal, Mehmet;
Umit, Elif Gulsum

Publication type:

Article

Thalidomide: Mechanisms of Action.

Published in:

International Reviews of Immunology, 2008, v. 27, n. 3, p. 111, doi. 10.1080/08830180801911339

By:

Paravar, Taraneh;
Lee, Delphine J.

Publication type:

Article

Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.

Published in:

Oncologist, 2016, v. 21, n. 1, p. 72, doi. 10.1634/theoncologist.2015-0176

By:

Kiesewetter, Barbara;
Troch, Marlene;
Mayerhoefer, Marius E.;
Dolak, Werner;
Simonitsch‐Klupp, Ingrid;
Raderer, Markus

Publication type:

Article

Nitric oxide mitigates thalidomide-induced abnormalities during germination and development of fennel seeds.

Published in:

Toxicology Research, 2021, v. 10, n. 4, p. 893, doi. 10.1093/toxres/tfab071

By:

Swaminathan, Akila;
Kalyani, Koneti Brahma;
Sudhagar, Senthil Kumar;
Bhuvaneswari, Srinivasan;
Nagalatha, S. Thupali;
Raj, T. Leon Stephan;
Sumantran, Venil N.;
Chatterjee, Suvro

Publication type:

Article

High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma.

Published in:

Clinical Transplantation, 2009, v. 23, n. 6, p. 839, doi. 10.1111/j.1399-0012.2008.00950.x

By:

Oyan, Basak;
Koc, Yener;
Ozdemir, Evren;
Kars, Ayse;
Turker, Alev;
Tekuzman, Gulten;
Kansu, Emin

Publication type:

Article

A lower dose of thalidomide is better than a high dose in metastatic renal cell carcinoma.

Published in:

BJU International, 2005, v. 96, n. 4, p. 536, doi. 10.1111/j.1464-410X.2005.05680.x

By:

Srinivas, Sandy;
Guardino, Alice E.

Publication type:

Article